$ARL
AMERICAN REALTY INVESTORS INC

2023 Q2 Form 10-Q Financial Statement

#000110223823000012 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $12.24M $11.69M
YoY Change 50.56% 50.1%
Cost Of Revenue $7.031M $6.106M
YoY Change 84.44% 51.59%
Gross Profit $5.208M $5.582M
YoY Change 20.64% 48.5%
Gross Profit Margin 42.55% 47.76%
Selling, General & Admin $5.867M $5.566M
YoY Change 16.13% -5.74%
% of Gross Profit 112.65% 99.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.200M $3.755M
YoY Change 1.49% 16.98%
% of Gross Profit 61.44% 67.27%
Operating Expenses $9.067M $8.668M
YoY Change 23.36% 5.02%
Operating Profit -$3.859M -$3.086M
YoY Change 27.23% -31.35%
Interest Expense $5.733M $8.545M
YoY Change -70.16% -10.81%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $352.0K $5.459M
YoY Change -98.25% -62.6%
Income Tax $49.00K $1.240M
% Of Pretax Income 13.92% 22.71%
Net Earnings $125.0K $2.978M
YoY Change -99.23% -73.68%
Net Earnings / Revenue 1.02% 25.48%
Basic Earnings Per Share $0.01 $0.18
Diluted Earnings Per Share $0.01 $0.18
COMMON SHARES
Basic Shares Outstanding 16.15M shares 16.15M shares
Diluted Shares Outstanding 16.15M shares 16.15M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.87M $55.34M
YoY Change 53.96% 301.19%
Cash & Equivalents $58.87M $55.34M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $105.1M $101.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $164.0M $157.2M
YoY Change 14.85% 36.95%
LONG-TERM ASSETS
Property, Plant & Equipment $501.3M $502.9M
YoY Change 76.69% 76.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $147.0M $170.8M
YoY Change 118.96% 84.82%
Other Assets $10.94M $55.19M
YoY Change -43.79% 155.13%
Total Long-Term Assets $896.8M $956.2M
YoY Change 51.15% 55.57%
TOTAL ASSETS
Total Short-Term Assets $164.0M $157.2M
Total Long-Term Assets $896.8M $956.2M
Total Assets $1.061B $1.113B
YoY Change 44.11% 52.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $47.60M $55.75M
YoY Change 47.51% 73.24%
Accrued Expenses $2.292M $2.641M
YoY Change -58.77% -19.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $49.89M $58.39M
YoY Change 31.89% 64.7%
LONG-TERM LIABILITIES
Long-Term Debt $184.4M $228.9M
YoY Change -41.84% -31.23%
Other Long-Term Liabilities $9.791M $9.791M
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $194.2M $238.6M
YoY Change -40.58% -30.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $49.89M $58.39M
Total Long-Term Liabilities $194.2M $238.6M
Total Liabilities $244.1M $297.0M
YoY Change -33.07% -21.42%
SHAREHOLDERS EQUITY
Retained Earnings $552.5M $552.4M
YoY Change 171.24% 194.78%
Common Stock $162.0K $162.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $616.6M $616.5M
YoY Change
Total Liabilities & Shareholders Equity $1.061B $1.113B
YoY Change 44.11% 52.64%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $125.0K $2.978M
YoY Change -99.23% -73.68%
Depreciation, Depletion And Amortization $3.200M $3.755M
YoY Change 1.49% 16.98%
Cash From Operating Activities -$9.994M $1.539M
YoY Change 107.91% -136.77%
INVESTING ACTIVITIES
Capital Expenditures $591.0K $5.653M
YoY Change -67.7% -11.53%
Acquisitions
YoY Change
Other Investing Activities $16.03M -$24.21M
YoY Change -43.05% -528.83%
Cash From Investing Activities $15.44M -$24.21M
YoY Change -45.15% -528.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $88.28M
YoY Change 285.13%
Cash From Financing Activities -46.16M -$89.13M
YoY Change 4214.39% 129.89%
NET CHANGE
Cash From Operating Activities -9.994M $1.539M
Cash From Investing Activities 15.44M -$24.21M
Cash From Financing Activities -46.16M -$89.13M
Net Change In Cash -40.72M -$111.8M
YoY Change -282.84% 199.66%
FREE CASH FLOW
Cash From Operating Activities -$9.994M $1.539M
Capital Expenditures $591.0K $5.653M
Free Cash Flow -$10.59M -$4.114M
YoY Change 59.48% -61.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001102238
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-15663
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
AMERICAN REALTY INVESTORS, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-6565852
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1603 Lyndon B. Johnson Freeway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75234
CY2023Q1 dei City Area Code
CityAreaCode
469
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
522-4200
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q1 dei Trading Symbol
TradingSymbol
ARL
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16152043 shares
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
502941000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
493821000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55340000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113445000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
55188000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
108883000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
158086000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
119787000 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
139361000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
139609000 usd
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
12669000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
28226000 usd
CY2023Q1 us-gaap Due From Related Parties
DueFromRelatedParties
101879000 usd
CY2022Q4 us-gaap Due From Related Parties
DueFromRelatedParties
108184000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
87956000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
85524000 usd
CY2023Q1 us-gaap Assets
Assets
1113420000 usd
CY2022Q4 us-gaap Assets
Assets
1197479000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
187179000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
188004000 usd
CY2023Q1 arl Bonds Payable Net
BondsPayableNet
41672000 usd
CY2022Q4 arl Bonds Payable Net
BondsPayableNet
129218000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
55750000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
53100000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2641000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
5198000 usd
CY2023Q1 us-gaap Deferred Gain On Sale Of Property
DeferredGainOnSaleOfProperty
9791000 usd
CY2022Q4 us-gaap Deferred Gain On Sale Of Property
DeferredGainOnSaleOfProperty
9791000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
297033000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
385311000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
2.00
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
2.00
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1800614 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1800614 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1800614 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1800614 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
1801000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1801000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16152043 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16152043 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16152043 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16152043 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
162000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
162000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62090000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62090000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
552412000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
549434000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
616465000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
613487000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
199922000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
198681000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
816387000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
812168000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1113420000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1197479000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
11009000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
7481000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
679000 usd
CY2022Q1 us-gaap Other Income
OtherIncome
306000 usd
CY2023Q1 us-gaap Revenues
Revenues
11688000 usd
CY2022Q1 us-gaap Revenues
Revenues
7787000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
6106000 usd
CY2022Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
4028000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
3102000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
2349000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3161000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2720000 usd
CY2023Q1 arl Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
2405000 usd
CY2022Q1 arl Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
3185000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
14774000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
12282000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3086000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4495000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
11503000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
6782000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
6348000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
6167000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
971000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3772000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1639000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2419000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5194000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
11148000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1240000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4219000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
14567000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1241000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3253000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2978000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
11314000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16152043 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16152043 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16152043 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16152043 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
812168000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4219000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
816387000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
336851000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
14567000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
351418000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4219000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
14567000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
11148000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
971000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3772000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1639000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3755000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3210000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
139000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2419000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5194000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5030000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5429000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-818000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
411000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1483000 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3311000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2650000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5334000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1539000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4186000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
248000 usd
CY2022Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
632000 usd
CY2023Q1 arl Origination And Advances Of Notes Receivable
OriginationAndAdvancesOfNotesReceivable
0 usd
CY2022Q1 arl Origination And Advances Of Notes Receivable
OriginationAndAdvancesOfNotesReceivable
537000 usd
CY2023Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
63956000 usd
CY2022Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
16584000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
27192000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 usd
CY2023Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
5653000 usd
CY2022Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
6388000 usd
CY2023Q1 us-gaap Payments For Leasing Costs
PaymentsForLeasingCosts
19000 usd
CY2022Q1 us-gaap Payments For Leasing Costs
PaymentsForLeasingCosts
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
28523000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
17976000 usd
CY2022Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24212000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5646000 usd
CY2023Q1 arl Repayment Of Mortgages Notes And Bonds Payable
RepaymentOfMortgagesNotesAndBondsPayable
89111000 usd
CY2022Q1 arl Repayment Of Mortgages Notes And Bonds Payable
RepaymentOfMortgagesNotesAndBondsPayable
38179000 usd
CY2023Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
CY2022Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
590000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
16000 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-89127000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38769000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-111800000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37309000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
222328000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72734000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110528000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35425000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4219000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
14567000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1241000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3253000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2978000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
11314000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16152043 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16152043 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16152043 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16152043 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
8720000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
10495000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113445000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50748000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
108883000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
21986000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
222328000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72734000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55340000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13794000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
55188000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
21631000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110528000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35425000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
832000 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15257000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
88279000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
22922000 usd
CY2023Q1 arl Repayment Of Mortgages Notes And Bonds Payable
RepaymentOfMortgagesNotesAndBondsPayable
89111000 usd
CY2022Q1 arl Repayment Of Mortgages Notes And Bonds Payable
RepaymentOfMortgagesNotesAndBondsPayable
38179000 usd
CY2023Q1 arl Distribution From Joint Venture Applied To Earn Out Obligation
DistributionFromJointVentureAppliedToEarnOutObligation
0 usd
CY2022Q1 arl Distribution From Joint Venture Applied To Earn Out Obligation
DistributionFromJointVentureAppliedToEarnOutObligation
7012000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
10708000 usd
CY2022Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
6996000 usd
CY2023Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
301000 usd
CY2022Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
485000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
11009000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
7481000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
11050000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
8819000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
8496000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
8177000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
7965000 usd
CY2023Q1 arl Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
19760000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
64267000 usd
CY2023Q1 us-gaap Land
Land
119203000 usd
CY2022Q4 us-gaap Land
Land
108933000 usd
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
360316000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
359904000 usd
CY2023Q1 us-gaap Tenant Improvements
TenantImprovements
26061000 usd
CY2022Q4 us-gaap Tenant Improvements
TenantImprovements
25611000 usd
CY2023Q1 us-gaap Development In Process
DevelopmentInProcess
66351000 usd
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
65427000 usd
CY2023Q1 arl Real Estate Investment Property Excluding Real Estate Held For Sale At Cost
RealEstateInvestmentPropertyExcludingRealEstateHeldForSaleAtCost
571931000 usd
CY2022Q4 arl Real Estate Investment Property Excluding Real Estate Held For Sale At Cost
RealEstateInvestmentPropertyExcludingRealEstateHeldForSaleAtCost
559875000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
68990000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
66054000 usd
CY2023Q1 us-gaap Real Estate Investments
RealEstateInvestments
502941000 usd
CY2022Q4 us-gaap Real Estate Investments
RealEstateInvestments
493821000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
11148000 usd
CY2023Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0476
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0467
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
139361000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
139609000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
187179000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
188004000 usd
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
642000 usd
CY2022Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
803000 usd
CY2023Q1 us-gaap Deferred Gain On Sale Of Property
DeferredGainOnSaleOfProperty
9791000 usd
CY2022Q4 us-gaap Deferred Gain On Sale Of Property
DeferredGainOnSaleOfProperty
9791000 usd
CY2023Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
41000 usd
CY2022Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
28000 usd
CY2023Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1199000 usd
CY2022Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
1240000 usd
CY2022Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
28000 usd

Files In Submission

Name View Source Status
0001102238-23-000012-index-headers.html Edgar Link pending
0001102238-23-000012-index.html Edgar Link pending
0001102238-23-000012.txt Edgar Link pending
0001102238-23-000012-xbrl.zip Edgar Link pending
arl-20230331.htm Edgar Link pending
arl-20230331.xsd Edgar Link pending
arl2023033110-qex311.htm Edgar Link pending
arl2023033110-qex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
arl-20230331_cal.xml Edgar Link unprocessable
arl-20230331_def.xml Edgar Link unprocessable
arl-20230331_lab.xml Edgar Link unprocessable
arl-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
arl-20230331_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending